Fentanyl has a strange public image problem. In the operating room, it is a carefully measured medication used by trained anesthesia professionals to control pain and blunt the body’s stress response during surgery. In the news, it is often discussed as a deadly street drug linked to the overdose crisis. Same molecule, wildly different settings. One is administered in micrograms by clinicians watching monitors like hawks. The other may appear unpredictably in the illegal drug supply, where nobody gets a dosage chart, a pulse oximeter, or a reassuring person in scrubs saying, “You’re doing great.”
So when an anesthesiologist says “no” to fentanyl, the point is not that fentanyl is evil, useless, or should be banished to the pharmacy dungeon. The point is more thoughtful: modern anesthesia should not use fentanyl automatically, reflexively, or simply because “that’s what we always do.” In many cases, an opioid-sparing or even opioid-free anesthesia plan may reduce side effects, improve recovery, and limit unnecessary opioid exposure. In other cases, fentanyl may still be the right tool. The art is knowing when to reach for itand when to leave it in the drawer.
The Real Meaning Behind “No”
The phrase “saying no to fentanyl” can sound dramatic, like a medical soap opera cliffhanger. But the more practical interpretation is this: do not treat fentanyl as the default seasoning sprinkled on every anesthetic plan. The original argument made by anesthesiologist Karen S. Sibert, MD, challenged the habitual use of fentanyl in clinical anesthesiology. Her point was not that anesthesiologists should have emotional relationships with drugsthankfully, no one needs to send fentanyl a breakup text. Drugs are tools. Tools should be selected for the job, not used because they happen to be nearby.
For decades, fentanyl has been popular in anesthesia because it works quickly, is powerful, and can be titrated in small doses. It can help control severe pain during and after surgery and can be used with other medicines before or during an operation. That usefulness explains why fentanyl became embedded in operating-room routines. But routines deserve periodic inspection. Medicine changes. Surgical recovery goals change. Patients are more complex. The opioid crisis has forced every clinician to ask a sharper question: “Is this opioid necessary for this patient, this procedure, and this moment?”
Fentanyl in Surgery Is Not the Same as Illicit Fentanyl
Before going further, let’s clean up one major misunderstanding. Medical fentanyl and illegally manufactured fentanyl are not used in the same way. In hospitals, fentanyl is prescribed, stored, measured, documented, and administered by trained professionals. In the illegal drug supply, fentanyl may be mixed into pills, heroin, cocaine, or other substances without the user’s knowledge. That is a completely different risk environment.
CDC overdose data show that synthetic opioidsprimarily illegally made fentanyl and fentanyl analogsremain a major driver of overdose deaths in the United States. That public health reality matters. It explains why the word “fentanyl” makes many patients tense up faster than a blood pressure cuff. Still, a monitored dose during anesthesia is not the same as an unknown dose from an unregulated source. Patients deserve clear, non-panicky explanations rather than one giant warning label with a siren attached.
Why Some Anesthesiologists Avoid Routine Fentanyl
There are several clinically reasonable reasons an anesthesiologist might avoid fentanyl unless it is clearly needed. First, opioids can depress breathing. That does not mean every patient who receives fentanyl stops breathing; it means respiratory depression is a known, serious risk that requires expertise, monitoring, and careful dosing. In the operating room, ventilation can be supported. In the recovery area, clinicians must remain alert for sedation, low oxygen levels, airway obstruction, and slowed breathing.
Second, opioids can contribute to nausea, vomiting, itching, constipation, urinary retention, grogginess, and delayed recovery. Nobody wakes from surgery hoping for the deluxe nausea package. For outpatient procedures especially, avoiding avoidable side effects can mean faster discharge, better comfort, and fewer miserable car rides home holding a plastic basin.
Third, some studies and clinical discussions have raised concern about opioid-induced hyperalgesia, a condition in which opioid exposure may paradoxically increase sensitivity to pain. This is not a simple “opioids cause pain” slogan. It is a complex topic influenced by dose, timing, drug choice, patient biology, and surgical trauma. But the possibility gives anesthesiologists another reason to avoid unnecessary opioid escalation.
Fourth, every opioid exposure should be considered in the broader context of opioid stewardship. Most patients who receive a small monitored anesthetic dose will not develop opioid use disorder from that single exposure. However, surgery can become the doorway to postoperative opioid prescriptions, refills, leftover pills in medicine cabinets, and prolonged use in vulnerable patients. The operating room is only one chapter in the story, but it is still part of the book.
Opioid-Free vs. Opioid-Sparing Anesthesia
The phrase “opioid-free anesthesia” means no opioids are used during the anesthetic. “Opioid-sparing anesthesia” means opioids are reduced and combined with other pain-control strategies. In real-world practice, opioid-sparing anesthesia is often the more flexible and patient-centered concept. It does not make fentanyl the villain. It simply refuses to make fentanyl the main character when the plot does not require it.
Modern multimodal analgesia uses several methods that work through different pathways. These may include acetaminophen, nonsteroidal anti-inflammatory drugs when appropriate, local anesthetic infiltration, nerve blocks, fascial plane blocks, epidural techniques, ketamine, dexmedetomidine, lidocaine infusions, gabapentinoids in selected patients, ice, positioning, and expectation-setting. The goal is not to throw every medication at the patient like a pharmacologic confetti cannon. The goal is to choose the right combination for the procedure and the person.
Regional anesthesia has become especially important. A well-placed nerve block or local anesthetic technique can reduce pain at the source, lower opioid requirements, and help patients move, breathe deeply, and participate in recovery. For some procedures, regional techniques are the difference between “I can walk to the bathroom” and “I have become one with the mattress.”
The Counterpoint: Fentanyl Can Still Be Useful
A responsible article cannot pretend that all fentanyl avoidance is automatically better. Newer research complicates the story. A large JAMA Surgery cohort study found that greater intraoperative fentanyl and hydromorphone administration was associated with lower pain scores and less opioid administration in the post-anesthesia care unit. Increased fentanyl was also associated with fewer opioid prescriptions at later follow-up points and less new persistent opioid use, without significant increases in measured adverse effects.
That does not mean “give everyone more fentanyl.” It means the operating room is not a bumper sticker. Pain during surgery is not harmless just because the patient is unconscious. Poorly controlled surgical nociception may contribute to worse recovery, higher postoperative opioid needs, and possibly persistent pain. The smarter lesson is optimization, not absolutism. Anesthesiologists should avoid both extremes: reflexively giving fentanyl to everyone and reflexively withholding it from everyone.
Who Might Benefit From a “No Fentanyl” Plan?
Some patients may be good candidates for avoiding or minimizing fentanyl. These include patients with obstructive sleep apnea, severe lung disease, high sensitivity to sedatives, previous severe nausea after anesthesia, older adults at risk for delirium, patients already taking multiple central nervous system depressants, and people with a history of opioid use disorder. In these cases, the anesthesiologist may design a plan that leans heavily on regional anesthesia, non-opioid medications, and close postoperative monitoring.
Patients undergoing procedures known to respond well to local or regional techniques may also benefit. For example, some breast surgeries, abdominal wall procedures, orthopedic operations, and minimally invasive surgeries can be managed with strong multimodal plans. The best approach depends on the exact surgery, the patient’s medical history, kidney and liver function, bleeding risk, medication allergies, and recovery goals.
Who Might Still Need Fentanyl?
Fentanyl may still be appropriate for major surgery, intense surgical stimulation, trauma cases, cardiac procedures, some cancer operations, and patients who need rapid, controllable opioid analgesia. It may also be useful when other medications are unsafe. For example, NSAIDs may not be suitable for certain patients with kidney disease, bleeding risk, stomach ulcers, or specific surgical concerns. Ketamine may not be ideal for everyone. Dexmedetomidine can lower heart rate and blood pressure. Nerve blocks are powerful, but they are not magic wands; even magic wands probably require consent forms.
In short, “no fentanyl” should mean “not automatically,” not “never.” The safest anesthetic is individualized. A thoughtful anesthesiologist asks: What pain pathways will this surgery activate? What risks does this patient bring? What side effects are most important to avoid? What will recovery look like in one hour, one day, and one week?
What Patients Should Ask Before Surgery
Patients do not need to become amateur anesthesiologists the night before surgery. Please do not fall into a 2 a.m. internet rabbit hole and arrive at the hospital demanding “three milligrams of vibes and a regional block.” But patients can ask smart questions.
Helpful Questions
- “Will opioids like fentanyl be part of my anesthesia plan?”
- “Are there opioid-sparing options for my procedure?”
- “Would a nerve block or local anesthetic technique help?”
- “I have sleep apnea, lung disease, or a history of opioid problems. How does that change the plan?”
- “What should I expect for pain control after I go home?”
- “How many opioid pills, if any, are usually needed after this surgery?”
The best time to discuss these issues is before surgery, not while being wheeled down the hallway wearing a gown with the structural confidence of a wet paper towel. Honest conversation helps the anesthesia team prepare a plan that respects both comfort and safety.
The Recovery Room Matters
One reason anesthesiologists think carefully about fentanyl is that the story does not end when the surgeon places the final stitch. The recovery room is where pain, breathing, nausea, anxiety, and sedation all show up for a group project. Opioid-induced respiratory depression remains a serious patient safety concern, especially after surgery, when patients may be sleepy, receiving other sedating medicines, or vulnerable because of sleep apnea or lung disease.
Good monitoring matters. So does good handoff communication. If a patient received opioids during surgery, recovery room staff need to know how much, when, and what other sedatives were used. If the patient has risk factors, clinicians may use enhanced oxygenation and ventilation monitoring. Safety is not one big heroic decision; it is a chain of small accurate decisions made by people who refuse to coast.
Beyond the Operating Room: The Prescription Problem
For many patients, the biggest opioid risk is not a tiny intraoperative dose of fentanyl. It is what happens after discharge. Too many pills, unclear instructions, and casual refills can turn short-term surgical pain into prolonged opioid exposure. Opioid stewardship means prescribing the lowest effective amount, combining non-opioid options when safe, educating patients about storage and disposal, and setting realistic expectations.
Patients should know that some pain after surgery is normal. The goal is tolerable pain that allows breathing, walking, sleeping, and healingnot necessarily a perfect zero on the pain scale. Aiming for zero pain at all costs can create new problems. Pain control should support function. If medication makes someone too sedated to move, cough, or think clearly, that is not a victory. That is just pain management wearing a fake mustache.
Why the “No” Is Really a “Think First”
The most persuasive version of “no to fentanyl” is not anti-science, anti-opioid, or anti-pain relief. It is anti-autopilot. It asks anesthesiologists to pause before giving a powerful drug and decide whether the benefit outweighs the risk. It also asks hospitals to build better systems: procedure-specific pain pathways, regional anesthesia access, patient education, safe prescribing habits, and monitoring protocols for high-risk patients.
That kind of “no” is actually a deeper “yes.” Yes to individualized care. Yes to multimodal analgesia. Yes to fewer side effects when possible. Yes to evidence over habit. Yes to respecting the reality of the opioid crisis without scaring patients away from legitimate medical care.
Experience-Based Reflections: What the Fentanyl Debate Looks Like in Real Life
In real perioperative care discussions, the fentanyl question rarely feels like a tidy classroom debate. It sounds more like a practical conversation among anxious patients, busy clinicians, and families who have read terrifying headlines. A patient may say, “Please don’t give me fentanyl. I’ve seen what it does.” What they often mean is, “Please don’t let me become another overdose story.” That fear deserves respect, not a smug lecture. A good clinician can explain that hospital fentanyl is controlled and monitored while still acknowledging that opioid exposure should never be casual.
Consider a patient with sleep apnea scheduled for outpatient shoulder surgery. A thoughtful anesthesia plan might include a regional block, acetaminophen, limited sedatives, careful airway planning, and a small backup dose of opioid only if needed. That patient may wake up comfortable, breathe well, and go home with clear instructions. The win is not ideological purity. The win is a patient who is safe, awake, comfortable, and not vomiting into a hospital-issued souvenir bag.
Now consider another patient undergoing a large abdominal operation. Avoiding fentanyl entirely might sound attractive, but untreated surgical stress and poor early pain control could make recovery harder. In that situation, a balanced plan may include regional analgesia, non-opioid medications, and carefully titrated fentanyl during the most stimulating parts of surgery. The “no fentanyl” mindset still helps because it prevents excess. But the final plan may not be zero. It may be “less, better timed, and paired with other tools.”
Patients with a history of opioid use disorder need especially careful planning. Some fear relapse. Some fear uncontrolled pain. Both fears are valid. A compassionate plan may involve addiction medicine input, continuation of medications for opioid use disorder when appropriate, regional anesthesia, non-opioid analgesics, and honest postoperative prescribing. The worst plan is silence. The best plan is direct, nonjudgmental, and specific.
Clinicians who practice opioid-sparing anesthesia often learn that communication is as important as medication. If patients expect zero pain, they may feel abandoned when normal surgical soreness appears. If they understand the goalmanageable pain, safe breathing, mobility, sleep, and healingthey are more likely to use medications wisely. Pain plans work best when they are explained in plain English before the patient is groggy, hungry, and wondering why hospital socks have such aggressive confidence.
The experience lesson is simple: fentanyl is not the hero, the villain, or the whole story. It is one tool in a large anesthesia toolbox. Sometimes the best decision is to avoid it. Sometimes the best decision is to use a small, precise dose. The anesthesiologist’s job is not to prove a philosophy. The job is to protect the patient through surgery and into recovery with the least harm and the most benefit possible.
Conclusion
Why does this anesthesiologist say “no” to fentanyl? Because powerful drugs should earn their place in a patient’s care plan. Fentanyl can be valuable, but it should not be automatic. Modern anesthesia is moving toward multimodal, opioid-sparing strategies that reduce unnecessary opioid exposure while still treating pain seriously. The smartest approach is not fear-based avoidance or old-school habit. It is individualized, evidence-aware, and honest about risk.
For patients, the takeaway is reassuring: you can ask about fentanyl without sounding difficult. You can discuss opioid-sparing anesthesia without rejecting pain control. And you can expect your anesthesia team to balance comfort, breathing safety, nausea prevention, surgical needs, and recovery goals. In other words, the best anesthetic plan is not “fentanyl always” or “fentanyl never.” It is “the right medicine, for the right patient, at the right time.” That may not fit on a bumper sticker, but it fits beautifully in an operating room.
